135 related articles for article (PubMed ID: 34519087)
1. Glucagon-like peptide-1 receptor agonist treatment of high carbohydrate intake-induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca
Durak A; Akkus E; Canpolat AG; Tuncay E; Corapcioglu D; Turan B
Clin Exp Pharmacol Physiol; 2022 Jan; 49(1):46-59. PubMed ID: 34519087
[TBL] [Abstract][Full Text] [Related]
2. Ticagrelor alleviates high-carbohydrate intake induced altered electrical activity of ventricular cardiomyocytes by regulating sarcoplasmic reticulum-mitochondria miscommunication.
Olgar Y; Durak A; Degirmenci S; Tuncay E; Billur D; Ozdemir S; Turan B
Mol Cell Biochem; 2021 Oct; 476(10):3827-3844. PubMed ID: 34114148
[TBL] [Abstract][Full Text] [Related]
3. Liraglutide provides cardioprotection through the recovery of mitochondrial dysfunction and oxidative stress in aging hearts.
Durak A; Turan B
J Physiol Biochem; 2023 May; 79(2):297-311. PubMed ID: 36515811
[TBL] [Abstract][Full Text] [Related]
4. A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats.
Durak A; Olgar Y; Degirmenci S; Akkus E; Tuncay E; Turan B
Cardiovasc Diabetol; 2018 Nov; 17(1):144. PubMed ID: 30447687
[TBL] [Abstract][Full Text] [Related]
5. Titin and CK2α are New Intracellular Targets in Acute Insulin Application-Associated Benefits on Electrophysiological Parameters of Left Ventricular Cardiomyocytes From Insulin-Resistant Metabolic Syndrome Rats.
Durak A; Bitirim CV; Turan B
Cardiovasc Drugs Ther; 2020 Aug; 34(4):487-501. PubMed ID: 32377826
[TBL] [Abstract][Full Text] [Related]
6. GLP-1 receptor agonist liraglutide protects cardiomyocytes from IL-1β-induced metabolic disturbance and mitochondrial dysfunction.
Zhang L; Tian J; Diao S; Zhang G; Xiao M; Chang D
Chem Biol Interact; 2020 Dec; 332():109252. PubMed ID: 32898504
[TBL] [Abstract][Full Text] [Related]
7. The intestine responds to heart failure by enhanced mitochondrial fusion through glucagon-like peptide-1 signalling.
Naruse G; Kanamori H; Yoshida A; Minatoguchi S; Kawaguchi T; Iwasa M; Yamada Y; Mikami A; Kawasaki M; Nishigaki K; Minatoguchi S
Cardiovasc Res; 2019 Nov; 115(13):1873-1885. PubMed ID: 30629149
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial targeted peptides preserve mitochondrial organization and decrease reversible myocardial changes in early swine metabolic syndrome.
Yuan F; Woollard JR; Jordan KL; Lerman A; Lerman LO; Eirin A
Cardiovasc Res; 2018 Mar; 114(3):431-442. PubMed ID: 29267873
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 regulates calcium homeostasis and electrophysiological activities of HL-1 cardiomyocytes.
Huang JH; Chen YC; Lee TI; Kao YH; Chazo TF; Chen SA; Chen YJ
Peptides; 2016 Apr; 78():91-8. PubMed ID: 26930508
[TBL] [Abstract][Full Text] [Related]
10. Exendin-4 inhibits structural remodeling and improves Ca
Chen J; Wang D; Wang F; Shi S; Chen Y; Yang B; Tang Y; Huang C
Peptides; 2017 Apr; 90():69-77. PubMed ID: 28242257
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress in cardiomyocytes contributes to decreased SERCA2a activity in rats with metabolic syndrome.
Balderas-Villalobos J; Molina-Muñoz T; Mailloux-Salinas P; Bravo G; Carvajal K; Gómez-Viquez NL
Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1344-53. PubMed ID: 23997093
[TBL] [Abstract][Full Text] [Related]
12. Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats.
Lee TI; Chen YC; Lin YK; Chung CC; Lu YY; Kao YH; Chen YJ
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987285
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 receptor mediated control of cardiac energy metabolism.
Al Batran R; Almutairi M; Ussher JR
Peptides; 2018 Feb; 100():94-100. PubMed ID: 29412838
[TBL] [Abstract][Full Text] [Related]
14. β
Tuncay E; Olgar Y; Durak A; Degirmenci S; Bitirim CV; Turan B
J Cell Physiol; 2019 Aug; 234(8):13370-13386. PubMed ID: 30613975
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 receptor action in the vasculature.
Almutairi M; Al Batran R; Ussher JR
Peptides; 2019 Jan; 111():26-32. PubMed ID: 30227157
[TBL] [Abstract][Full Text] [Related]
16. GLP-1 receptor agonist liraglutide reverses long-term atypical antipsychotic treatment associated behavioral depression and metabolic abnormalities in rats.
Sharma AN; Ligade SS; Sharma JN; Shukla P; Elased KM; Lucot JB
Metab Brain Dis; 2015 Apr; 30(2):519-27. PubMed ID: 25023888
[TBL] [Abstract][Full Text] [Related]
17. Liraglutide preserves intracellular calcium handling in isolated murine myocytes exposed to oxidative stress.
Palee S; Chattipakorn SC; Chattipakorn N
Physiol Res; 2017 Nov; 66(5):889-895. PubMed ID: 28730832
[TBL] [Abstract][Full Text] [Related]
18. Ageing-associated increase in SGLT2 disrupts mitochondrial/sarcoplasmic reticulum Ca
Olgar Y; Tuncay E; Degirmenci S; Billur D; Dhingra R; Kirshenbaum L; Turan B
J Cell Mol Med; 2020 Aug; 24(15):8567-8578. PubMed ID: 32652890
[TBL] [Abstract][Full Text] [Related]
19. Abnormal amounts of intracellular calcium regulatory proteins in SHRSP.Z-Lepr(fa)/IzmDmcr rats with metabolic syndrome and cardiac dysfunction.
Kagota S; Maruyama K; Tada Y; Wakuda H; Nakamura K; Kunitomo M; Shinozuka K
Can J Physiol Pharmacol; 2013 Feb; 91(2):124-33. PubMed ID: 23458196
[TBL] [Abstract][Full Text] [Related]
20. A sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin comparison with insulin shows important effects on Zn
Olgar Y; Turan B
Can J Physiol Pharmacol; 2019 Jun; 97(6):528-535. PubMed ID: 30444646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
